Yale JF, Major-Pedersen A, Catarig AM, Jain R, et al. Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programme. Diabetes Obes Metab 2024 Aug 8. doi: 10.1111/dom.15794.
PMID: 39118222